Sharnsure LTD has been contributing in the development of a novel platform through a collaboration of European oncology stakeholders, including public health and commercial providers, in an innovative initiative to develop a platform to better understand the real world use of cancer therapies. This includes multi-level analytics enabled through low latency data analysis compliant with the strictest requirements of patient confidentiality and security.
Discover more at: odn-cancer.com |